We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+1.44%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$332M
AUM Growth
-$2.34M
Cap. Flow
-$3.18M
Cap. Flow %
-0.96%
Top 10 Hldgs %
36.19%
Holding
214
New
5
Increased
52
Reduced
94
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 17.57%
2 Healthcare 17.32%
3 Financials 11.88%
4 Industrials 8.47%
5 Communication Services 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DG icon
101
Dollar General
DG
$28B
$657K 0.2%
4,969
+750
+18% +$105K
CI icon
102
Cigna
CI
$75.4B
$652K 0.2%
1,973
MRK icon
103
Merck
MRK
$319B
$644K 0.19%
5,205
-144
-3% -$18.5K
AAP icon
104
Advance Auto Parts
AAP
$3.34B
$643K 0.19%
10,147
-150
-1% -$10.7K
MDY icon
105
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.5B
$629K 0.19%
1,176
-1,019
-46% -$548K
BLK icon
106
Blackrock
BLK
$170B
$615K 0.19%
781
-51
-6% -$39.8K
EXPE icon
107
Expedia Group
EXPE
$35.4B
$615K 0.19%
4,880
+4
+0.1% +$493
MDT icon
108
Medtronic
MDT
$108B
$609K 0.18%
7,737
-131
-2% -$10.7K
TER icon
109
Teradyne
TER
$57.7B
$608K 0.18%
4,098
-200
-5% -$25.4K
DE icon
110
Deere & Co
DE
$160B
$600K 0.18%
1,607
+74
+5% +$28.9K
CVX icon
111
Chevron
CVX
$385B
$596K 0.18%
3,813
VEU icon
112
Vanguard FTSE All-World ex-US ETF
VEU
$66.2B
$595K 0.18%
10,152
+3,999
+65% +$235K
PSX icon
113
Phillips 66
PSX
$84.4B
$590K 0.18%
4,182
AMN icon
114
AMN Healthcare
AMN
$1.31B
$568K 0.17%
11,095
+3,925
+55% +$222K
STT icon
115
State Street
STT
$50.6B
$561K 0.17%
7,577
LLY icon
116
Eli Lilly
LLY
$1.01T
$557K 0.17%
615
-10
-2% -$8K
COR icon
117
Cencora
COR
$60.5B
$547K 0.16%
2,426
-172
-7% -$39.8K
CRM icon
118
Salesforce
CRM
$149B
$540K 0.16%
2,099
-48
-2% -$12.8K
SOLV icon
119
Solventum
SOLV
$14.8B
$520K 0.16%
+9,841
New +$597K
EBAY icon
120
eBay
EBAY
$50.4B
$512K 0.15%
9,529
INCY icon
121
Incyte
INCY
$24.1B
$502K 0.15%
8,285
+105
+1% +$5.95K
NVO
122
Novo Nordisk
NVO
$206B
$490K 0.15%
3,430
DUK icon
123
Duke Energy
DUK
$97.7B
$485K 0.15%
4,843
BAX icon
124
Baxter International
BAX
$13.6B
$471K 0.14%
14,089
+285
+2% +$10.5K
NFLX icon
125
Netflix
NFLX
$300B
$460K 0.14%
6,810
-90
-1% -$5.62K

Similar funds

Roberts, Glore & Co's Q2 2024 Portfolio in Review

As of Q2 2024, Roberts, Glore & Co held 214 positions worth $332M, down 0.7% from $334M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Roberts, Glore & Co's Q2 2024 filing shows 5 new, 52 increased, 94 reduced and 9 closed positions. Its largest new stake was iShares MSCI EAFE ETF: 13,496 shares worth $1.06M. The largest sale was Apple, an estimated $988K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Roberts, Glore & Co's largest Q2 2024 buy was iShares MSCI EAFE ETF: 13,496 shares worth $1.06M.
  • Roberts, Glore & Co added most to Vanguard Morningstar Total Stock Market ETF in Q2 2024, an estimated $1.37M increase.
  • Roberts, Glore & Co's biggest Q2 2024 reduction was Apple, cutting an estimated $988K.
  • Roberts, Glore & Co fully exited Western Asset Mortgage Opportunity Fund in Q2 2024, selling an estimated $363K.
  • Roberts, Glore & Co's ten largest holdings make up 36% of its $332M portfolio in Q2 2024.
  • Roberts, Glore & Co opened 5 new positions and closed 9 in Q2 2024.
  • Roberts, Glore & Co's portfolio value fell 0.7% quarter-over-quarter to $332M.

Based on Roberts, Glore & Co's 13F filing for Q2 2024, filed 14 Aug 2024.